Lab-on-a-Chip and Microfluidics World Congress 2025 Set to Explore Next-Gen Diagnostics, 3D Bioprinting, and Commercialization
The 18th Annual Lab-on-a-Chip & Microfluidics World Congress 2025, now officially included in the ResearchAndMarkets.com conference offering, is poised to once again bring together innovators, researchers, and industry stakeholders from across the globe. This year’s event will take place at the VOCO Hotel in Laguna Hills, California, and promises to be one of the most comprehensive yet, with a special theme: “From Research to Commercialization.”
Since its inception nearly two decades ago, this congress has established itself as a cornerstone for the lab-on-a-chip (LOAC) and microfluidics communities. The 2025 edition aims to spotlight not only breakthrough research but also the technologies and strategies accelerating the real-world application of microfluidic solutions across healthcare, life sciences, and engineering.
Focus on Real-World Applications and Commercial Readiness
The 2025 conference will emphasize translating research into market-ready solutions, recognizing the growing demand for lab-on-a-chip devices across clinical diagnostics, environmental monitoring, pharmaceutical R&D, and biofabrication.
Key application areas featured in the program include:
- Point-of-care diagnostics and global health solutions
- Body-on-a-chip and organs-on-a-chip platforms for drug screening and disease modeling
- 3D bioprinting and biofabrication, particularly where microfluidics intersect with engineered tissue models
- Single-cell analysis and rare cell capture techniques for oncology and precision medicine
- Digital, droplet, and centrifugal microfluidics for assay automation
By focusing on commercialization pathways, the congress will address the growing need for scalable manufacturing technologies, regulatory clarity, and collaborative development models that bridge academia and industry.
Diverse, Global Perspectives Driving Innovation
A major strength of the Lab-on-a-Chip & Microfluidics World Congress is its truly international scope. This year’s speaker lineup, poster presenters, sponsors, and exhibitors will represent North America, Europe, and the Asia-Pacific region, bringing unique insights and perspectives to global challenges and opportunities.
The conference will also serve as a networking hub for:
- Startup founders and entrepreneurs aiming to enter or scale in the microfluidics market
- Academic researchers seeking to commercialize new device concepts
- Healthcare companies interested in diagnostic innovation and miniaturized testing
- Biotech and pharma professionals exploring next-gen drug discovery tools
With such a wide range of stakeholders, the congress is designed to foster interdisciplinary collaboration, from engineering and materials science to biomedical research and clinical application.
Co-Located Tracks and Parallel Sessions
To maximize learning and networking opportunities, the 2025 event will run multiple co-located tracks concurrently, all accessible to registered attendees. These include:
- Lab-on-a-Chip and Microfluidics: Technologies, Companies, and Commercialization 2025
- Innovations in Extracellular Vesicles Research 2025: Technologies, Tools, Demos & Applications
Attendees can mix and match sessions based on their interests, allowing for cross-pollination between different research disciplines and commercial domains.
Conference Agenda Highlights
The 2025 agenda is packed with high-impact sessions covering a wide range of technical and translational topics. Some of the key themes and discussion areas include:
- 3D-Printing and its Convergence with Microfluidics and Lab-on-a-Chip
- Biofabrication and Bioprinting Enabled by Microfluidic Devices
- Digital, Droplet, and Centrifugal Microfluidics for Lab Automation
- Point-of-Care and Global Health Diagnostic Solutions
- Emerging Technologies for Rare Cell Capture and Circulating Biomarker Analysis
- Microfluidics for Single-Cell Biology and Precision Therapeutics
- Manufacturing Technologies and Commercial Strategies for LOAC Devices
- New Market Entrants and Emerging Global Innovators in Microfluidics
Each session is designed to bring together case studies, technical demonstrations, and commercial insights that will benefit startups, research labs, and global enterprises alike.
Esteemed Speakers and Scientific Leadership
This year’s speaker roster includes a distinguished group of researchers and industry leaders who are shaping the future of lab-on-a-chip technologies. Confirmed speakers include:
- Andrew Godwin – Professor and Deputy Director, KU Cancer Center, University of Kansas Medical Center
- Gregory Nordin – Professor, Brigham Young University
- Stefano Begolo – President of ALine Inc., and Conference Co-Chairperson
- Brian Cunningham – Intel Alumni Endowed Chair, University of Illinois at Urbana-Champaign
- Jing Chen – Founder & CEO, Hicomp Microtech
- Steve Soper – Foundation Distinguished Professor, University of Kansas, Director, Center of BioModular Multi-Scale System for Precision Medicine
- Dino Di Carlo – Chair of Bioengineering, University of California Los Angeles, and Conference Co-Chairperson
- Noah Malmstadt – Professor, Dept. of Chemical Engineering & Materials Science, University of Southern California
These speakers bring a mix of academic excellence, engineering ingenuity, and entrepreneurial expertise, ensuring that the sessions go beyond theory into implementation.
Exhibition: The Latest Tools and Technologies
Alongside the main conference, an exhibition hall will feature leading solution providers from around the world. Attendees will have hands-on access to:
- New microfluidic chips and fabrication tools
- 3D bioprinters and bioinks
- Integrated diagnostics platforms
- Fluid handling systems
- Analytical software and AI-driven lab automation tools
This exhibit floor provides a valuable opportunity to discover new products, explore collaborations, and discuss implementation with solution engineers and commercial representatives.
Conclusion: A Global Platform for Microfluidic Advancement
The Lab-on-a-Chip and Microfluidics World Congress 2025 promises to be a comprehensive gathering of the brightest minds and most forward-thinking companies in the field. With its emphasis on moving from cutting-edge research to viable commercial applications, the event is set to inspire innovation, spark collaborations, and help guide the next decade of development in lab-on-a-chip and microfluidic technologies.
Whether you’re a scientist, engineer, entrepreneur, or investor, this congress offers the insight, access, and global connections needed to make an impact in this fast-growing space.
For more information about this conference visit https://www.researchandmarkets.com/r/un58a6
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
